Moreover, our recent study revealed that DDX39B protected against sorafenib-induced ferroptosis through enhancement of antioxidant capacity and maintenance of mitochondrial function, and this function of DDX39B was dependent on its ATPase activity to facilitate the splicing and cytoplasmic export of GPX4 mRNA in HCC [158]. Here, DDX39B is linked to hepatocellular carcinoma.